Drug Profile
Epoetin alfa biosimilar - Sun Pharmaceutical Industires
Alternative Names: CeritonLatest Information Update: 30 Oct 2021
Price :
$50
*
At a glance
- Originator Ranbaxy Laboratories
- Developer Sun Pharmaceutical Industries
- Class Antianaemics; Recombinant erythropoietins
- Mechanism of Action Erythropoiesis stimulants; Erythropoietin receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Anaemia
Most Recent Events
- 25 Mar 2015 Ranbaxy Laboratories has been acquired by Sun Pharmaceutical Industries
- 01 May 2010 Launched for Anaemia in India prior to May 2010 (Parenteral)